Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
出版年份 2022 全文链接
标题
Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 23, Pages 14917
出版商
MDPI AG
发表日期
2022-11-29
DOI
10.3390/ijms232314917
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Patient-derived xenograft (PDX) models, applications and challenges in cancer research
- (2022) Shahrokh Abdolahi et al. Journal of Translational Medicine
- Targeting metastatic cancer
- (2021) Karuna Ganesh et al. NATURE MEDICINE
- CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance
- (2021) Koran S. Harris et al. Scientific Reports
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
- (2021) Gerit Theil et al. Oncology Letters
- High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
- (2021) Hao Shu et al. Journal of Orthopaedic Surgery and Research
- Cancer and stem cells
- (2021) Wen Yin et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
- (2021) Sarah I. M. Sutherland et al. Frontiers in Immunology
- Dynamic EMT: a multi‐tool for tumor progression
- (2021) Simone Brabletz et al. EMBO JOURNAL
- Cancer stem cell characteristics and their potential as therapeutic targets
- (2021) Jacqueline R. Lim et al. MEDICAL ONCOLOGY
- Going beyond Polycomb: EZH2 functions in prostate cancer
- (2021) Su H. Park et al. ONCOGENE
- Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
- (2021) Vincenza Conteduca et al. npj Precision Oncology
- Prostate cancer dormancy and recurrence
- (2021) Frank C. Cackowski et al. CANCER LETTERS
- Tumour metabolism and its unique properties in prostate adenocarcinoma
- (2020) David A. Bader et al. Nature Reviews Urology
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- Epithelial–mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis
- (2020) Andrew T. Plygawko et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Is There a Role for Immunotherapy in Prostate Cancer?
- (2020) Alessandro Rizzo et al. Cells
- EMT, cancer stem cells and autophagy; The three main axes of metastasis
- (2020) Ghader Babaei et al. BIOMEDICINE & PHARMACOTHERAPY
- Genomic and phenotypic heterogeneity in prostate cancer
- (2020) Michael C. Haffner et al. Nature Reviews Urology
- Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
- (2020) Gaetano Aurilio et al. Cells
- The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
- (2019) Wenjuan Mei et al. Cancers
- Targeting the androgen receptor and overcoming resistance in prostate cancer
- (2019) David J. Einstein et al. CURRENT OPINION IN ONCOLOGY
- Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer
- (2019) Alessandro Sciarra et al. MEDICINE
- Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
- (2019) Gianluca Civenni et al. Frontiers in Oncology
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- Epithelial mesenchymal transition and resistance in endocrine-related cancers
- (2019) Zoran Culig BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer stem cells in prostate cancer radioresistance
- (2019) Tsing Tsao et al. CANCER LETTERS
- The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
- (2018) HectorR Contreras et al. ASIAN JOURNAL OF ANDROLOGY
- EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers
- (2018) Rama Soundararajan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer
- (2018) Diogo A. Bastos et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas
- (2018) Toshihide Matsumoto et al. MOLECULAR CARCINOGENESIS
- Metastatic niche functions and therapeutic opportunities
- (2018) Toni Celià-Terrassa et al. NATURE CELL BIOLOGY
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
- (2018) Kaixuan Wang et al. ONCOGENE
- A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling
- (2018) Federico Bocci et al. Oncotarget
- The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer
- (2018) Nancy Farfán et al. Scientific Reports
- Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
- (2018) Yun Zhang et al. Frontiers of Medicine
- Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
- (2018) Vincenzo Di Nunno et al. Frontiers in Oncology
- Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
- (2018) Jie Ni et al. BMC CANCER
- Cancer stem cells (CSCs) in cancer progression and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
- (2018) Adam Sharp et al. JOURNAL OF CLINICAL INVESTIGATION
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches
- (2017) Dong Fang et al. INTERNATIONAL JOURNAL OF UROLOGY
- Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines
- (2017) Atsushi Mizokami et al. INTERNATIONAL JOURNAL OF UROLOGY
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
- (2017) Davide Pradella et al. Molecular Cancer
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Cellular determinants and microenvironmental regulation of prostate cancer metastasis
- (2017) Kiera Rycaj et al. SEMINARS IN CANCER BIOLOGY
- Epithelial-mesenchymal transition in prostate cancer: an overview
- (2017) Micaela Montanari et al. Oncotarget
- Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis
- (2017) Koran S. Harris et al. Stem Cells International
- Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview
- (2017) Do Kim et al. Journal of Clinical Medicine
- REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer
- (2017) Yi-Ting Chang et al. Scientific Reports
- Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis
- (2017) Claudio Luchini et al. Scientific Reports
- Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer
- (2016) M. Raschid Hoda et al. EXPERT OPINION ON PHARMACOTHERAPY
- Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
- (2016) Aparna Jayachandran et al. Journal of Hematology & Oncology
- Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer
- (2016) Lori E. Lowes et al. Oncotarget
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
- (2015) M. Ruscetti et al. CANCER RESEARCH
- Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications
- (2015) Qu Deng et al. ENDOCRINE-RELATED CANCER
- SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells
- (2015) LUIS A. OSORIO et al. Molecular Medicine Reports
- Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
- (2015) FEDERICO F. CIFUENTES et al. ONCOLOGY REPORTS
- Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2
- (2015) Admire Matsika et al. PATHOLOGY
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse (Mus musculus) anterior prostate
- (2015) FEDERICO F. CIFUENTES et al. Oncology Letters
- CD117+ cells in the circulation are predictive of advanced prostate cancer
- (2015) Bethany A. Kerr et al. Oncotarget
- Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche
- (2015) Catherine A. Sánchez et al. Oncotarget
- SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression
- (2015) Silvia Esposito et al. Oncotarget
- SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis
- (2015) Marco Vincenzo Russo et al. Oncotarget
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
- (2014) P Massoner et al. BRITISH JOURNAL OF CANCER
- Bone-induced c-kit expression in prostate cancer: A driver of intraosseous tumor growth
- (2014) Leandro E. Mainetti et al. INTERNATIONAL JOURNAL OF CANCER
- Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer
- (2014) VIVIANA CASTILLO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer
- (2014) CRISTIAN E. POBLETE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin
- (2014) Gagan Deep et al. Molecular Cancer
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression
- (2014) XIULAN ZHAO et al. ONCOLOGY REPORTS
- Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
- (2013) Neha Tiwari et al. CANCER CELL
- Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy
- (2013) VASU TUMATI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis
- (2013) Steven M. Frisch et al. JOURNAL OF CELL SCIENCE
- Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease
- (2013) A. Marije Hoogland et al. PROSTATE
- Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis
- (2012) Enrique A Castellón et al. BIOLOGICAL RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
- (2012) Toni Celià-Terrassa et al. JOURNAL OF CLINICAL INVESTIGATION
- Slug, a Unique Androgen-Regulated Transcription Factor, Coordinates Androgen Receptor to Facilitate Castration Resistance in Prostate Cancer
- (2012) Kaijie Wu et al. MOLECULAR ENDOCRINOLOGY
- Isolated, disseminated and circulating tumour cells in prostate cancer
- (2012) David Schilling et al. Nature Reviews Urology
- CXCR4 Expression in Prostate Cancer Progenitor Cells
- (2012) Anna Dubrovska et al. PLoS One
- Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells
- (2012) Jing Jiao et al. PLoS One
- Metastatic Progression of Prostate Cancer and E-Cadherin
- (2011) Aaron P. Putzke et al. AMERICAN JOURNAL OF PATHOLOGY
- PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate Cancer
- (2011) M. Katie Conley-LaComb et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression
- (2011) Marc D. Bullock et al. BIOLOGY OF THE CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins
- (2011) Catherine Sánchez et al. PROSTATE
- Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer
- (2011) Goran Benko et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Expression of Pluripotent Stem Cell Reprogramming Factors by Prostate Tumor Initiating Cells
- (2010) Kyung-Mi Bae et al. JOURNAL OF UROLOGY
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
- (2009) George J. Klarmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs
- (2009) Catherine Sánchez et al. PROSTATE
- Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
- (2009) Ganesh S. Palapattu et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More